New research, led by experts at the University of Nottingham, has found that repeated doses of paracetamol in people aged 65 ...

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to ...

Research, led by experts at the University of Nottingham, has found that repeated doses of paracetamol in people aged 65 and ...

Esperion to Receive an Upfront Payment and Near-Term Milestones Along with Tiered Royalties on Product Sales –– Israel-Based Commercial ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Despite following the same basic recommendations as the adult guidelines, the pediatric LN guidelines included special ...

Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigatio ...

LYNPARZA® (olaparib) Demonstrated Clinically Meaningful Prolonged Survival Benefit in Early Breast Cancer in OlympiA Phase 3 Trial ...

U.S. total addressable market for five initial indications is $25 to $33 billionREMINDER: Business Update Conference Call begins at 4:30 p.m.